Cytokinetics (CYTK) Tax Rate (2010)
Cytokinetics (CYTK) posted quarterly Tax Rate of 1.41% for Q3 2010.
Cytokinetics (CYTK) Tax Rate (2010) Analysis & Trends
Cytokinetics (CYTK) has reported Tax Rate for 1 consecutive years, with 1.41% the latest figure, recorded in Q3 2010.
- In Q3 2010, Tax Rate changed N/A year-over-year to 1.41%; the TTM figure through Jun 2014 stood at 0.76% (changed N/A YoY), while the FY2010 annual figure was 0.36%, down 25.0% from the prior year.
- Tax Rate was little changed at 1.41% in Q3 2010 per CYTK's latest filing.
- Across five years, Tax Rate topped out at 1.41% in Q3 2010 and bottomed at 1.41% in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | 1.41% |
| Sep 30, 2010 | 1.41% |
| Sep 30, 2010 | 1.41% |